Peter Thiel-backed psychedelic drug maker aims to raise $100M in IPO
Psychedelic drugmaker ATAI Life Science, which backed by billionaire investor Peter Thiel, said it is planning to raise $100 million in an initial public offering. The Berlin-based company — which tests drugs like ketamine, DMT and psilocybin, the...